Sign in
4

Changes in Ownership

RxSight, Inc. Filed Acc 0000950170-23-064616

Director sold 500,000 shares at an average $27.18 ($13,590,750)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Tammenoms Bakker Juliet Director 2023-11-14 Sale −100,000 $27.13 $2,712,590 894,313 I: show line 1 in the form
Tammenoms Bakker Juliet Director 2023-11-15 Sale −400,000 $27.20 $10,878,160 494,313 I: show line 2 in the form
Open-market sales · 500,000 sh · avg $27.18 · $13,590,750
Loading xslF345X05/ownership.xml…